Jupiter Neurosciences secures $100M term sheet for MDMA therapeutic rights May 20, 2026 07:44AM
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech May 20, 2026 07:38AM